| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3E ARHGEF19 TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP27 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.51e-10 | 279 | 84 | 13 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D3E ARHGEF19 TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP27 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.89e-07 | 507 | 84 | 13 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D3E ARHGEF19 TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP27 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.89e-07 | 507 | 84 | 13 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme activator activity | TBC1D3E ARHGEF19 TBC1D3 TBC1D3H TBC1D3L TBC1D3D BAD ARHGAP27 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.64e-07 | 656 | 84 | 14 | GO:0008047 |
| GeneOntologyMolecularFunction | enzyme regulator activity | TBC1D3E ARHGEF19 TBC1D3 TBC1D3H TBC1D3L TBC1D3D PPP1R15B BAD PAPLN SMO ARHGAP27 TBC1D3I TBC1D3G SSPOP TBC1D3C TBC1D3B HSPB1 TBC1D3K TBC1D3F | 5.12e-06 | 1418 | 84 | 19 | GO:0030234 |
| GeneOntologyMolecularFunction | steroid 11-beta-monooxygenase activity | 1.75e-05 | 2 | 84 | 2 | GO:0004507 | |
| GeneOntologyMolecularFunction | corticosterone 18-monooxygenase activity | 1.75e-05 | 2 | 84 | 2 | GO:0047783 | |
| GeneOntologyMolecularFunction | heme binding | 4.83e-04 | 154 | 84 | 5 | GO:0020037 | |
| GeneOntologyMolecularFunction | molecular function activator activity | TBC1D3E ARHGEF19 TBC1D3 TBC1D3H TBC1D3L TBC1D3D BAD ARHGAP27 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.92e-04 | 1233 | 84 | 14 | GO:0140677 |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 6.43e-04 | 164 | 84 | 5 | GO:0046906 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 1.32e-03 | 13 | 84 | 2 | GO:0016713 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E ARHGEF19 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.43e-14 | 109 | 85 | 12 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E ARHGEF19 TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.52e-10 | 244 | 85 | 12 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E ARHGEF19 TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP27 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.12e-09 | 335 | 85 | 13 | GO:0043087 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | TBC1D3E ARHGEF19 LMF1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D PPP1R15B BAD TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.76e-09 | 499 | 85 | 15 | GO:0051345 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | TBC1D3E BCL2L12 ARHGEF19 LMF1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D PPP1R15B BAD PAPLN ARHGAP27 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.45e-08 | 878 | 85 | 18 | GO:0051336 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | TBC1D3E ARHGEF19 LMF1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D PPP1R15B CYP27B1 BAD TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.96e-06 | 1028 | 85 | 16 | GO:0043085 |
| GeneOntologyBiologicalProcess | amino-acid betaine catabolic process | 5.02e-05 | 3 | 85 | 2 | GO:0006579 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | TGFBR3 TBC1D3E ARHGEF19 LMF1 TBC1D3 TBC1D3H TBC1D3L TBC1D3D PPP1R15B CYP27B1 BAD TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 6.29e-05 | 1430 | 85 | 17 | GO:0044093 |
| GeneOntologyBiologicalProcess | regulation of blood volume by renal aldosterone | 1.00e-04 | 4 | 85 | 2 | GO:0002017 | |
| MousePheno | abnormal urine progesterone level | 1.46e-05 | 2 | 54 | 2 | MP:0011545 | |
| MousePheno | abnormal urine deoxycorticosterone level | 1.46e-05 | 2 | 54 | 2 | MP:0011552 | |
| MousePheno | decreased urine corticosterone level | 1.46e-05 | 2 | 54 | 2 | MP:0011550 | |
| MousePheno | increased urine deoxycorticosterone level | 1.46e-05 | 2 | 54 | 2 | MP:0011553 | |
| MousePheno | increased urine progesterone level | 1.46e-05 | 2 | 54 | 2 | MP:0011546 | |
| MousePheno | abnormal adrenal gland zona glomerulosa morphology | 8.74e-05 | 4 | 54 | 2 | MP:0008293 | |
| MousePheno | decreased urine aldosterone level | 8.74e-05 | 4 | 54 | 2 | MP:0011541 | |
| MousePheno | abnormal urine aldosterone level | 8.74e-05 | 4 | 54 | 2 | MP:0011539 | |
| MousePheno | abnormal urine corticosterone level | 8.74e-05 | 4 | 54 | 2 | MP:0011548 | |
| MousePheno | decreased urine hormone level | 8.74e-05 | 4 | 54 | 2 | MP:0014459 | |
| MousePheno | increased adrenal gland zona fasciculata size | 1.45e-04 | 5 | 54 | 2 | MP:0014286 | |
| MousePheno | uterus adenomyosis | 2.18e-04 | 6 | 54 | 2 | MP:0009221 | |
| MousePheno | increased urine hormone level | 2.18e-04 | 6 | 54 | 2 | MP:0014458 | |
| MousePheno | adrenal gland hyperplasia | 2.18e-04 | 6 | 54 | 2 | MP:0009078 | |
| MousePheno | abnormal urine hormone level | 3.04e-04 | 7 | 54 | 2 | MP:0011538 | |
| MousePheno | pituitary gland hyperplasia | 3.04e-04 | 7 | 54 | 2 | MP:0000635 | |
| MousePheno | decreased thymus weight | 3.55e-04 | 36 | 54 | 3 | MP:0004956 | |
| MousePheno | increased circulating angiotensin II level | 4.04e-04 | 8 | 54 | 2 | MP:0031232 | |
| MousePheno | increased angiotensin II level | 4.04e-04 | 8 | 54 | 2 | MP:0031229 | |
| MousePheno | decreased circulating renin level | 6.46e-04 | 10 | 54 | 2 | MP:0003353 | |
| MousePheno | abnormal adrenocortical cell morphology | 6.46e-04 | 10 | 54 | 2 | MP:0008291 | |
| MousePheno | abnormal adrenal gland zona fasciculata size | 7.88e-04 | 11 | 54 | 2 | MP:0014284 | |
| MousePheno | uterus cyst | 7.88e-04 | 11 | 54 | 2 | MP:0009082 | |
| MousePheno | increased circulating pituitary hormone level | 8.48e-04 | 110 | 54 | 4 | MP:0005117 | |
| MousePheno | abnormal endometrium morphology | 8.85e-04 | 49 | 54 | 3 | MP:0004896 | |
| MousePheno | abnormal circulating angiotensin II level | 9.43e-04 | 12 | 54 | 2 | MP:0031230 | |
| MousePheno | abnormal angiotensin II level | 9.43e-04 | 12 | 54 | 2 | MP:0031227 | |
| MousePheno | hypokalemia | 9.43e-04 | 12 | 54 | 2 | MP:0004119 | |
| MousePheno | enlarged pituitary gland | 9.43e-04 | 12 | 54 | 2 | MP:0000636 | |
| MousePheno | abnormal corpus luteum morphology | 1.03e-03 | 116 | 54 | 4 | MP:0002679 | |
| MousePheno | increased renin activity | 1.29e-03 | 14 | 54 | 2 | MP:0005582 | |
| MousePheno | decreased circulating mineralocorticoid level | 1.29e-03 | 14 | 54 | 2 | MP:0003374 | |
| MousePheno | increased urine osmolality | 1.29e-03 | 14 | 54 | 2 | MP:0008055 | |
| MousePheno | increased circulating adrenocorticotropin level | 1.29e-03 | 14 | 54 | 2 | MP:0001748 | |
| MousePheno | decreased circulating aldosterone level | 1.29e-03 | 14 | 54 | 2 | MP:0002667 | |
| MousePheno | endometrium hyperplasia | 1.29e-03 | 14 | 54 | 2 | MP:0009092 | |
| MousePheno | abnormal amino acid derivative level | 1.36e-03 | 125 | 54 | 4 | MP:0021145 | |
| Domain | TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 8.34e-15 | 49 | 80 | 10 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.95e-14 | 53 | 80 | 10 | PF00566 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.91e-14 | 55 | 80 | 10 | PS50086 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.91e-14 | 55 | 80 | 10 | IPR000195 |
| Domain | DUF4939 | 8.89e-06 | 10 | 80 | 3 | PF16297 | |
| Domain | DUF4939 | 8.89e-06 | 10 | 80 | 3 | IPR032549 | |
| Domain | LDOC1-rel | 1.22e-05 | 11 | 80 | 3 | IPR032567 | |
| Domain | Cyt_P450_mitochondrial | 1.81e-05 | 2 | 80 | 2 | IPR002399 | |
| Domain | MAGE | 4.11e-04 | 34 | 80 | 3 | SM01373 | |
| Domain | MAGE | 4.88e-04 | 36 | 80 | 3 | PS50838 | |
| Domain | MAGE | 4.88e-04 | 36 | 80 | 3 | PF01454 | |
| Domain | MHD_dom | 4.88e-04 | 36 | 80 | 3 | IPR002190 | |
| Domain | Haem_peroxidase | 7.97e-04 | 10 | 80 | 2 | IPR010255 | |
| Domain | An_peroxidase | 7.97e-04 | 10 | 80 | 2 | PF03098 | |
| Domain | PEROXIDASE_3 | 7.97e-04 | 10 | 80 | 2 | PS50292 | |
| Domain | Haem_peroxidase_animal | 7.97e-04 | 10 | 80 | 2 | IPR019791 | |
| Domain | - | 7.97e-04 | 10 | 80 | 2 | 1.10.640.10 | |
| Domain | Cyt_P450_CS | 1.52e-03 | 53 | 80 | 3 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 1.87e-03 | 57 | 80 | 3 | PS00086 | |
| Domain | - | 1.97e-03 | 58 | 80 | 3 | 1.10.630.10 | |
| Domain | p450 | 1.97e-03 | 58 | 80 | 3 | PF00067 | |
| Domain | Cyt_P450 | 2.17e-03 | 60 | 80 | 3 | IPR001128 | |
| Domain | MAGE_N | 3.27e-03 | 20 | 80 | 2 | SM01392 | |
| Domain | EPHD | 3.96e-03 | 22 | 80 | 2 | PS51805 | |
| Domain | MAGE_N | 3.96e-03 | 22 | 80 | 2 | PF12440 | |
| Domain | MAGE_N | 3.96e-03 | 22 | 80 | 2 | IPR021072 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K | 4.67e-11 | 99 | 49 | 9 | M46448 |
| Pathway | KEGG_MEDICUS_REFERENCE_STEROID_HORMONE_BIOSYNTHESIS_PROGESTERONE_TO_CORTISOL_CORTISONE | 1.18e-04 | 5 | 49 | 2 | M47522 | |
| Pathway | REACTOME_CHOLINE_CATABOLISM | 1.76e-04 | 6 | 49 | 2 | M27619 | |
| Pathway | REACTOME_CHOLINE_CATABOLISM | 1.76e-04 | 6 | 49 | 2 | MM15329 | |
| Pathway | REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES | 2.19e-04 | 34 | 49 | 3 | M27461 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 4.42e-04 | 43 | 49 | 3 | MM15873 | |
| Pathway | REACTOME_GLUCOCORTICOID_BIOSYNTHESIS | 5.23e-04 | 10 | 49 | 2 | M27076 | |
| Pathway | REACTOME_GLUCOCORTICOID_BIOSYNTHESIS | 6.38e-04 | 11 | 49 | 2 | MM14750 | |
| Pathway | REACTOME_MINERALOCORTICOID_BIOSYNTHESIS | 7.64e-04 | 12 | 49 | 2 | MM14749 | |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.09e-29 | 11 | 86 | 11 | 16863688 |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 6.93e-10 | 74 | 86 | 7 | 16625196 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 9403077 | ||
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 5.83e-08 | 4 | 86 | 3 | 12359748 | |
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 8406013 | ||
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 12604796 | ||
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 8471161 | ||
| Pubmed | 2.90e-07 | 6 | 86 | 3 | 35247097 | ||
| Pubmed | 5.07e-07 | 7 | 86 | 3 | 20662904 | ||
| Pubmed | A family of neofunctionalized Ty3/gypsy retrotransposon genes in mammalian genomes. | 2.37e-06 | 11 | 86 | 3 | 16093683 | |
| Pubmed | 2.37e-06 | 11 | 86 | 3 | 15716091 | ||
| Pubmed | 5.21e-06 | 14 | 86 | 3 | 19955443 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 17651452 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 23150505 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 34743356 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 35012455 | ||
| Pubmed | Role of genetic variation in regulation of aldosterone biosynthesis. | 6.04e-06 | 2 | 86 | 2 | 21164264 | |
| Pubmed | Polymorphisms in CYP11B2 and CYP11B1 genes associated with primary hyperaldosteronism. | 6.04e-06 | 2 | 86 | 2 | 20339375 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 20808686 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 8645611 | ||
| Pubmed | Expression and localization of cytochrome P450(11beta,aldo) mRNA in the frog brain. | 6.04e-06 | 2 | 86 | 2 | 12231255 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 20634641 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 1303253 | ||
| Pubmed | Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets. | 6.04e-06 | 2 | 86 | 2 | 21519965 | |
| Pubmed | Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children. | 6.04e-06 | 2 | 86 | 2 | 21625068 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 16110193 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 26066897 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 1741400 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 32540969 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 26047574 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 26324851 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 18651133 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 7669222 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 22083159 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 22933298 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 2783417 | ||
| Pubmed | Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism. | 6.04e-06 | 2 | 86 | 2 | 2256920 | |
| Pubmed | Editorial: polymorphisms in CYP11B genes and 11-hydroxylase activity. | 6.04e-06 | 2 | 86 | 2 | 15699546 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 18162527 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 38341019 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 20708777 | ||
| Pubmed | Molecular genetic studies on the biosynthesis of aldosterone in humans. | 6.04e-06 | 2 | 86 | 2 | 22217843 | |
| Pubmed | Mechanistic study of polychlorinated biphenyl 126-induced CYP11B1 and CYP11B2 up-regulation. | 6.04e-06 | 2 | 86 | 2 | 16396990 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 24837548 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 30046010 | ||
| Pubmed | Familial and phenotypic associations of the aldosterone Renin ratio. | 6.04e-06 | 2 | 86 | 2 | 19820005 | |
| Pubmed | [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. | 6.04e-06 | 2 | 86 | 2 | 18397978 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 1518866 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 22622494 | ||
| Pubmed | Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production. | 6.04e-06 | 2 | 86 | 2 | 15062555 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 23761669 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 17075030 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 17075029 | ||
| Pubmed | Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). | 6.04e-06 | 2 | 86 | 2 | 2592361 | |
| Pubmed | CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity. | 6.04e-06 | 2 | 86 | 2 | 15507509 | |
| Pubmed | Polymorphism of CYP11B2 determines salt sensitivity in Japanese. | 6.04e-06 | 2 | 86 | 2 | 17296872 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 23314847 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 17980006 | ||
| Pubmed | Association between aldosterone production and variation in the 11beta-hydroxylase (CYP11B1) gene. | 6.04e-06 | 2 | 86 | 2 | 16984984 | |
| Pubmed | Evidence for local aldosterone synthesis in the large intestine of the mouse. | 6.04e-06 | 2 | 86 | 2 | 35288482 | |
| Pubmed | Homeostatic responses in the adrenal cortex to the absence of aldosterone in mice. | 6.04e-06 | 2 | 86 | 2 | 15731365 | |
| Pubmed | Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase. | 6.04e-06 | 2 | 86 | 2 | 18039983 | |
| Pubmed | Cyp11b1 null mouse, a model of congenital adrenal hyperplasia. | 6.04e-06 | 2 | 86 | 2 | 19029289 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 15522937 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 36861295 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 36778748 | ||
| Pubmed | Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. | 1.81e-05 | 3 | 86 | 2 | 8111631 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 2546938 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 16118390 | ||
| Pubmed | Interaction of CYP11B1 (cytochrome P-45011 beta) with CYP11A1 (cytochrome P-450scc) in COS-1 cells. | 1.81e-05 | 3 | 86 | 2 | 10411633 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 18974272 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 29356306 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 17984374 | ||
| Pubmed | Different isozymes of mouse 11 beta-hydroxylase produce mineralocorticoids and glucocorticoids. | 1.81e-05 | 3 | 86 | 2 | 1686470 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 2233742 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 33271253 | ||
| Pubmed | Mislocalization of protein kinase A drives pathology in Cushing's syndrome. | 1.81e-05 | 3 | 86 | 2 | 35830806 | |
| Pubmed | Diversity of human copy number variation and multicopy genes. | 1.81e-05 | 3 | 86 | 2 | 21030649 | |
| Pubmed | The prolactin regulatory element-binding regulates of the 11beta-hydroxylase gene. | 1.81e-05 | 3 | 86 | 2 | 18801336 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 11932209 | ||
| Pubmed | Testis-enriched ferlin, FER1L5, is required for Ca2+-activated acrosome reaction and male fertility. | 1.81e-05 | 3 | 86 | 2 | 36696506 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 21467193 | ||
| Pubmed | Control of renin secretion from kidneys with renin cell hyperplasia. | 1.81e-05 | 3 | 86 | 2 | 24285498 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 7750493 | ||
| Pubmed | Antiaging Gene Klotho Regulates Adrenal CYP11B2 Expression and Aldosterone Synthesis. | 1.81e-05 | 3 | 86 | 2 | 26471128 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 28355486 | ||
| Pubmed | Angiotensin II induces coordinated calcium bursts in aldosterone-producing adrenal rosettes. | 1.81e-05 | 3 | 86 | 2 | 32245948 | |
| Pubmed | Zona Glomerulosa-Derived Klotho Modulates Aldosterone Synthase Expression in Young Female Mice. | 3.61e-05 | 4 | 86 | 2 | 38573585 | |
| Pubmed | Adrenal Abcg1 Controls Cholesterol Flux and Steroidogenesis. | 3.61e-05 | 4 | 86 | 2 | 38301271 | |
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 37102205 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 11903322 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 19342457 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 29440508 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 23303406 | ||
| Pubmed | Single-Cell Resolution and Quantitation of Targeted Glucocorticoid Delivery in the Thymus. | 3.61e-05 | 4 | 86 | 2 | 30917317 | |
| Pubmed | Beta-Catenin Causes Adrenal Hyperplasia by Blocking Zonal Transdifferentiation. | 3.61e-05 | 4 | 86 | 2 | 32320669 | |
| Pubmed | β-Catenin-Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer. | 3.61e-05 | 4 | 86 | 2 | 37129912 | |
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 8372604 | ||
| Pubmed | Wnt/β-catenin activation cooperates with loss of p53 to cause adrenocortical carcinoma in mice. | 3.61e-05 | 4 | 86 | 2 | 32561853 | |
| Pubmed | β-Catenin and FGFR2 regulate postnatal rosette-based adrenocortical morphogenesis. | 3.61e-05 | 4 | 86 | 2 | 32245949 | |
| Interaction | CLIC3 interactions | 6.48e-06 | 63 | 84 | 5 | int:CLIC3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.74e-15 | 149 | 86 | 11 | chr17q12 |
| Cytoband | 17q12 | 1.28e-06 | 99 | 86 | 5 | 17q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q24 | 4.96e-06 | 355 | 86 | 7 | chr8q24 | |
| Cytoband | 8q24.3 | 1.28e-03 | 113 | 86 | 3 | 8q24.3 | |
| Cytoband | 8p21.3 | 2.33e-03 | 38 | 86 | 2 | 8p21.3 | |
| Cytoband | 22q13.33 | 2.33e-03 | 38 | 86 | 2 | 22q13.33 | |
| Cytoband | 5q14.1 | 2.46e-03 | 39 | 86 | 2 | 5q14.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq26 | 4.14e-03 | 171 | 86 | 3 | chrXq26 | |
| GeneFamily | Cytochrome P450 family 11 | 1.81e-05 | 3 | 45 | 2 | 1007 | |
| GeneFamily | Ferlin family | 9.03e-05 | 6 | 45 | 2 | 828 | |
| GeneFamily | MAGE family | 1.33e-04 | 40 | 45 | 3 | 1136 | |
| GeneFamily | Autophagy related | 3.05e-03 | 33 | 45 | 2 | 1022 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON | 7.44e-07 | 157 | 84 | 7 | M17936 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.03e-10 | 90 | 86 | 9 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | JCAD TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B CNGA4 TBC1D3K TBC1D3F | 3.87e-09 | 242 | 86 | 11 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B CNGA4 TBC1D3K TBC1D3F | 1.52e-08 | 213 | 86 | 10 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B CNGA4 TBC1D3K TBC1D3F | 1.52e-08 | 213 | 86 | 10 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D PAPLN TBC1D3G TBC1D3C TBC1D3B CNGA4 TBC1D3K TBC1D3F | 1.82e-08 | 281 | 86 | 11 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D PAPLN TBC1D3G TBC1D3C TBC1D3B CNGA4 TBC1D3K TBC1D3F | 1.82e-08 | 281 | 86 | 11 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | JCAD TBC1D3 TBC1D3H TBC1D3L TBC1D3D EXT1 TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 6.87e-08 | 320 | 86 | 11 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | JCAD NRBP2 ARL6IP6 TBC1D3 TBC1D3H TBC1D3L TBC1D3D ADCK5 TRO BAD EXT1 PROSER2 TBC1D3G TBC1D3C ABCA7 TBC1D3B HERPUD1 TBC1D3K TBC1D3F | 1.34e-07 | 1153 | 86 | 19 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_1000 | DMGDH JCAD ENDOD1 NRBP2 TBC1D3 TBC1D3H ZNF862 FER1L4 SLC4A10 NTN5 IFITM10 SSPOP TBC1D3C TBC1D3B PRRT4 TBC1D3F | 1.88e-06 | 986 | 86 | 16 | PCBC_ratio_ECTO_vs_SC_1000 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | MEP1A TGFBR3 NRBP2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D C6orf89 TBC1D3G TBC1D3C TBC1D3B HERPUD1 TBC1D3K BHMT TBC1D3F | 1.86e-05 | 1049 | 86 | 15 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TGFBR3 ENDOD1 NRBP2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D RTL8B SMO TBC1D3G TBC1D3C ABCA7 TBC1D3B TBC1D3K TBC1D3F | 2.48e-05 | 1075 | 86 | 15 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | TGFBR3 ENDOD1 NRBP2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D C6orf89 RTL8B TRO BAD TBC1D3G TBC1D3C ABCA7 TBC1D3B TBC1D3K TBC1D3F | 6.97e-05 | 1466 | 86 | 17 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| Disease | adrenal cortical adenoma (is_marker_for) | 6.04e-06 | 2 | 73 | 2 | DOID:0050891 (is_marker_for) | |
| Disease | Glucocorticoid-remediable aldosteronism | 6.04e-06 | 2 | 73 | 2 | C1260386 | |
| Disease | congenital adrenal hyperplasia (implicated_via_orthology) | 1.81e-05 | 3 | 73 | 2 | DOID:0050811 (implicated_via_orthology) | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 6.01e-05 | 5 | 73 | 2 | DOID:446 (is_implicated_in) | |
| Disease | Conn Syndrome | 9.00e-05 | 6 | 73 | 2 | C1384514 | |
| Disease | Hyperaldosteronism | 9.00e-05 | 6 | 73 | 2 | C0020428 | |
| Disease | protocadherin alpha-7 measurement | 1.26e-04 | 7 | 73 | 2 | EFO_0801973 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 1.26e-04 | 7 | 73 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | Alzheimer disease | 1.67e-04 | 8 | 73 | 2 | cv:C0002395 | |
| Disease | pancreatic cancer (is_implicated_in) | 1.75e-04 | 112 | 73 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | Calcium channel blocker use measurement | 1.89e-04 | 213 | 73 | 5 | EFO_0009930 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 2.15e-04 | 9 | 73 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) measurement | 2.15e-04 | 9 | 73 | 2 | EFO_0800517 | |
| Disease | protein FAM163B measurement | 2.15e-04 | 9 | 73 | 2 | EFO_0802936 | |
| Disease | androstenedione measurement | 2.68e-04 | 10 | 73 | 2 | EFO_0007972 | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 3.27e-04 | 11 | 73 | 2 | EFO_0021862 | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 3.27e-04 | 11 | 73 | 2 | EFO_0801461 | |
| Disease | granulysin measurement | 6.21e-04 | 15 | 73 | 2 | EFO_0008144 | |
| Disease | CCL4 measurement | 1.11e-03 | 20 | 73 | 2 | EFO_0004751 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 1.46e-03 | 90 | 73 | 3 | DOID:11832 (biomarker_via_orthology) | |
| Disease | peak expiratory flow | 1.47e-03 | 498 | 73 | 6 | EFO_0009718 | |
| Disease | apolipoprotein L1 measurement | 1.75e-03 | 25 | 73 | 2 | EFO_0021854 | |
| Disease | pre-eclampsia (is_implicated_in) | 1.75e-03 | 25 | 73 | 2 | DOID:10591 (is_implicated_in) | |
| Disease | acute kidney failure (implicated_via_orthology) | 2.04e-03 | 27 | 73 | 2 | DOID:3021 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | JCAD TGFBR3 MXRA5 ARL6IP6 CYP11B2 FBRSL1 CD46 BRD1 SSPOP CCDC157 | 2.19e-03 | 1392 | 73 | 10 | EFO_0005763 |
| Disease | selenium measurement | 2.35e-03 | 29 | 73 | 2 | EFO_0006331 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GWIQPRRPRDPTPSF | 266 | Q14137 | |
| EFPFGLEPRVATRWD | 266 | Q93088 | |
| PGFAWEPFRGLELPR | 891 | Q9HCM7 | |
| RPAAAPRRPFSWEDV | 686 | O95696 | |
| SPFRGRSRSAPPNLW | 91 | Q92934 | |
| PRLWSFRSGQPARVP | 61 | Q9UKB5 | |
| RAPSVPPFLRWAGYR | 31 | Q9HB09 | |
| PWPSPAVFFRRNVRG | 21 | Q3MIX3 | |
| RAGPVRFPSWKFPDR | 31 | Q569K6 | |
| FPIPDLRSDQERGPW | 756 | Q96BY7 | |
| FPAGAEVTNRPSPWR | 206 | Q9Y4P1 | |
| NFPFRRSYWCGPRPP | 766 | Q8IZY2 | |
| EDFRRPLQGEWRRPP | 681 | Q8IXT5 | |
| PLQGEWRRPPEDDFR | 686 | Q8IXT5 | |
| GWFPFRPRPVQNFPN | 306 | Q15011 | |
| FPVAPEELRAPGSRW | 51 | Q8IW93 | |
| QFPEPNSFRPARWLG | 421 | O15528 | |
| PRRPPLQWRYSEVSF | 351 | Q9NSY0 | |
| WQRGRIPFFVKPPNA | 451 | Q13823 | |
| PPRYEFLWGPRARAE | 266 | A8MXT2 | |
| NSDPPRYEFLWGPRA | 261 | Q96M61 | |
| RRECPFPSWRFPGLL | 6 | P15529 | |
| WVRCPFEQRRFPTPP | 281 | Q6ZVW7 | |
| RAWPPSPGRFRVEEG | 926 | Q9P266 | |
| QRPELQFFPLRKGPW | 866 | A9Z1Z3 | |
| FPRNTERPPETGPWR | 1011 | Q96Q04 | |
| PFQRSRWDPETGRSP | 151 | Q9NRD8 | |
| FRAPRPAPGGAEQRW | 81 | O94919 | |
| VLQAPRPRPRTFFSW | 546 | Q969U6 | |
| RERSPSPSFRWPFSG | 326 | P49585 | |
| PNPRVPLSRVFFASW | 521 | P05164 | |
| DPDAPSRAEPRQRFW | 96 | Q96S96 | |
| VPFSLLRGPSWDPFR | 6 | P04792 | |
| DPARPDGSWTFAQRP | 201 | Q9ULW3 | |
| WSPGQPSFLQPRELR | 476 | O15234 | |
| PRFPDALRPFVPWDQ | 56 | Q16394 | |
| FRPLPQPREAWGLSD | 2251 | Q9H799 | |
| EPGVWVARPPRFRAQ | 436 | Q9H972 | |
| EARVPLDGAFWIPRP | 51 | A6NMD0 | |
| LFPRPERYNPQRWLD | 416 | P15538 | |
| RPGREAAQWFPPQDR | 26 | Q8TF76 | |
| RPSFRRTNWFEPVGS | 506 | Q9UI17 | |
| LFPRPERYNPQRWLD | 416 | P19099 | |
| FPFPYPWRRPLNRSQ | 226 | Q6UWU4 | |
| EGGPRPWILEPSRFF | 676 | Q5VU65 | |
| PWGRVGFPSISPFRF | 1056 | Q5JY77 | |
| LIPNGFPLERPWARF | 231 | Q2WGJ9 | |
| RRWRNPIPFPETFDG | 21 | Q9BWD3 | |
| RRWRNPIPFPETFDG | 21 | Q17RB0 | |
| RRWRNPIPFPETFDG | 21 | A6ZKI3 | |
| FRRTDVPAQPGPTRW | 466 | Q7Z4K8 | |
| VRARFRSPSNPPAAW | 2736 | A2VEC9 | |
| PGFWRDPSQPIFSRR | 256 | Q8WTR8 | |
| PFREGRPGEWRTPAA | 216 | Q86WR7 | |
| NGLRDPNTRWTFPIP | 66 | Q16819 | |
| WHVRREPGGRPFYLP | 46 | Q6ZUM4 | |
| PQDSPYGRWRFQIPA | 196 | Q92561 | |
| PRLPTDLDVEGPWFR | 456 | B9A6J9 | |
| RLGPRAGFRFWPPFF | 11 | Q5SWA1 | |
| AGFRFWPPFFPRRSQ | 16 | Q5SWA1 | |
| FPAAAGSRAQPRRWP | 91 | Q8N6S5 | |
| WVYPDPAQPGFERLR | 201 | Q8IV77 | |
| PRLPTDLDVEGPWFR | 456 | A6NDS4 | |
| PRLPTDLDVEGPWFR | 456 | P0C7X1 | |
| SGQRPRRWCPPPFFY | 216 | Q9Y2T7 | |
| RPFEPQALGLSPSWR | 36 | Q99611 | |
| PNSRPPEYEFFWGLR | 596 | Q12816 | |
| PRLPTDLDVEGPWFR | 456 | A6NER0 | |
| RAEGFPPPAIEWQRD | 1066 | O95428 | |
| PDTWERFVRRFGPLQ | 406 | Q5K4L6 | |
| RDDRGWFVTPLGPNP | 796 | Q6U841 | |
| LPQGRSPFAPRESWR | 541 | C9JH25 | |
| PRLPTDLDVEGPWFR | 456 | A0A087X179 | |
| RGWPDFLRCTPDRFP | 161 | Q99835 | |
| RIFFEASRPPWFTPR | 506 | Q8NB14 | |
| PRSDRFPGRSVWAEP | 441 | A2A288 | |
| NPELFRKFGRGPEPW | 51 | O60290 | |
| PIWAARFRSIRDPPG | 211 | O60290 | |
| KEPFRPGSFRPNWQL | 61 | Q9UDY6 | |
| PRLPTDLDVEGPWFR | 456 | A0A087WVF3 | |
| PRLPTDLDVEGPWFR | 456 | Q6DHY5 | |
| PRLPTDLDVEGPWFR | 456 | Q8IZP1 | |
| PRLPTDLDVEGPWFR | 456 | A0A087X1G2 | |
| PRLPTDLDVEGPWFR | 456 | A0A087WXS9 | |
| PRLPTDLDVEGPWFR | 456 | Q6IPX1 | |
| LPFPFPDISRRVWNE | 401 | Q03167 | |
| ELRRFELPFDWPRCP | 81 | O14686 | |
| ELRPYFRDRGWPLPG | 551 | Q96S06 | |
| GTPAPQISWIFPDRR | 1976 | Q9NR99 |